Celldex Therapeutics Inc Cash Flow Reinvestment Rate
Celldex Therapeutics Inc cash flow reinvestment rate. Celldex Therapeutics Inc (CLDX) has a Cash Flow Reinvestment Rate of 0.02x as of December 2008, reinvesting $26.75K (capex $26.75K ) from operating cash flow of $1.29 Million. See Celldex Therapeutics Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Celldex Therapeutics Inc (1986–2008)
Cash flow reinvestment rate of Celldex Therapeutics Inc from 1986 to 2008. Historical reinvestment intensity for Celldex Therapeutics Inc across 3 annual periods. Explore CLDX debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Celldex Therapeutics Inc Cash Flow Reinvestment Rate by Year (1986–2008)
Celldex Therapeutics Inc cash flow reinvestment rate by year from 1986 to 2008. Year-by-year capital reinvestment analysis for Celldex Therapeutics Inc. For the full cash flow conversion analysis, see Celldex Therapeutics Inc cash conversion from operations.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2008 | 0.07x | $1.30 Million | $18.28 Million | $1.30 Million | ▼ -79.3% |
| 2006 | 0.35x | $9.32 Million | $27.00 Million | $9.32 Million | — |
| 1986 | 0.00x | $0.00 | $12.30 Million | $0.00 | — |